Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Clinical Decision Support Tool.

  • Published 2017 in Gastroenterology


Increase thiopurine dose or switch to different drug class Consider changing to different drug class; for toxicity, consider alternative causes *TPMT level does not negate the need for routine lab monitoring after starting thiopurine with CBC and liver enzymes **Active IBD is defined as objective findings of active disease based on biochemical markers… (More)
DOI: 10.1053/j.gastro.2017.07.039